TrialJournal of neuro-oncology2013

Safety of second-line chemotherapy with non-conventional fotemustine schedule in recurrent high grade gliomas: a single institution experience.

P Gaviani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.